|
SRC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
7.799400E-04 |
| Normal-vs-Stage3 |
2.44249065417534E-15 |
| Normal-vs-Stage4 |
1.74740999999701E-05 |
| Stage1-vs-Stage2 |
3.308800E-01 |
| Stage1-vs-Stage3 |
1.724570E-01 |
| Stage1-vs-Stage4 |
4.122200E-02 |
| Stage2-vs-Stage3 |
7.500200E-02 |
| Stage2-vs-Stage4 |
2.073800E-02 |
| Stage3-vs-Stage4 |
1.221830E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.66930000000676E-06 |
| Normal-vs-Asian |
3.59700003116359E-09 |
| Caucasian-vs-AfricanAmerican |
2.010000E-01 |
| Caucasian-vs-Asian |
2.379800E-01 |
| AfricanAmerican-vs-Asian |
7.259800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54587453948807E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
6.809600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.33066907387547E-16 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
4.71510000044084E-07 |
| Normal-vs-Age(81-100Yrs) |
7.497100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.983560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.048800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.811200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.828600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.713200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.554400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.659600E-01 |
| Classical-VS-Follicular |
4.39449998612673E-09 |
| Classical-VS-Other |
7.490400E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
8.238700E-04 |
| Tall-VS-Other |
8.662400E-01 |
| Tall-VS-Normal |
1.02560000492247E-08 |
| Follicular-VS-Other |
9.137800E-02 |
| Follicular-VS-Normal |
3.003300E-03 |
| Other-VS-Normal |
4.841400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78879133727605E-12 |
| Normal-vs-N1 |
1.24139998280981E-09 |
| N0-vs-N1 |
3.151000E-01 |
|
|
